Novartis has actually defeated its sales assumptions for sclerosis medication Kesimpta, which was initially established by Genmab.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/genmab-to-receive-more-in-royalties-as-novartis-exceeds-expectations/
Genmab to receive more in royalties as Novartis exceeds expectations
赞 (0)
关于作者
Bavarian Nordic to expand smallpox vaccine indication to toddlers
上一篇
30 10 月, 2024 7:17 上午
Analysts: Zealand Pharma and Sanofi could be a perfect match
下一篇
30 10 月, 2024 7:17 上午
相关推荐
-
Samsung, Salesforce invest in $60M round for Seattle cybersecurity startup Protect AI
From left: Shield AI CTO Badar Ahmed; President Daryan Dehghanpisheh; and CEO Ian Swanson. (Shield AI Photograph) Seattle cybersecurity startup Protect AI is on a roll. The corpora…
-
The Impact of 5G on the Logistics Industry: Advancing Connectivity and Efficiency
5G is playing a significantly substantial duty in logistics, where information move rate and protection are critical. With faster, a lot more dependable connection, logistics syste…
-
Neo Energy Metals to acquire two uranium, gold projects in South Africa’s Witwatersrand basin
Neo Uranium Resources Beisa Mine, a subsidiary of South Africa- and London-listed Neo Power Metals, has actually authorized a binding contract to get the Beisa North and Beisa Sout…
-
Metaverse Consumer Thematic Intelligence Report 2024: How FMCG Companies can Adapt to Online Developments, Associated Technologies and Platforms in the Future – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Thematic Intelligence: the Metaverse in Shopper” report has been added to ResearchAndMarkets.com’s providing. The metavers…
-
Downers on Your Team Will Jeopardize Your Business Survival
Do not be a version for negativeness at the workplace– it can eliminate your occupation along with your organization …Read More
